Skip to main content

Table 1 Patient characteristics

From: Bone mineral density in Jamaican men on androgen deprivation therapy for prostate cancer

Variables

Group 1

Group 2

Group 3

p value

N

133

43

170

 

Age (yrs)

75±7.4a,b

67±8.1

65±12.0

<0.0001

Weight (kg)

70.4±10.8

71.5±11.6

72.8±14.4

0.4

Height (cm)

166.5±6.8b

169.4±6.8

169.6±7.3

0.006

BMI (kg/m2)

25.4±3.9

25.0±3.9

25.2±4.2

0.8

T score

-1.6±1.5a,b

-0.9±1.1

-0.7±1.4

<0.0001*

Normal Bone density†

40 (30)

23 (55)

95 (58)

158 (46)

Osteopenia†

56 (41)

18 (40)

59 (33)

133 (37)

Osteoporosis†

37 (29)

2 (5)

16 (9)

56 (17)

  1. Values are mean±s.d.
  2. †values are counts (%).
  3. Group 1- prostate cancer patients receiving androgen deprivation therapy.
  4. Group 2- prostate cancer patients, hormonally naiive.
  5. Group 3- non prostate cancer patients; hormonally naiive.
  6. BMI- Body Mass Index.
  7. p value comparison of means by analysis of variance (ANOVA) with post hoc comparisons by Scheffe.
  8. a- Group 1 vs Group 2: p<0.005.
  9. b- Group 1 vs Group 3: p<0.005.
  10. c- Group 2 vs Group 3: p<0.005.
  11. * p value comparison of ranks by Kruskal Wallis procedure with post hoc comparisons by Wilcoxon test.
  12. a- Group 1 vs Group 2: p<0.005.
  13. b- Group 1 vs Group 3: p<0.005.
  14. c- Group 2 vs Group 3: p<0.005.
Back to article page

Infectious Agents and Cancer

ISSN: 1750-9378

Contact us